Hepatocellular Carcinoma with Sarcomatoid Change without Anticancer Therapies
Hepatocellular carcinoma (HCC) with sarcomatoid change is a rare neoplasm of the liver, and recurrent therapies for HCC such as transcatheter arterial chemoembolization and percutaneous ablation therapy are presumed to promote sarcomatoid change. A 73-year-old man was admitted to our hospital diagno...
Main Authors: | Naoki Yoshida, Yutaka Midorikawa, Takahiro Kajiwara, Nao Yoshida, Hisashi Nakayama, Masahiko Sugitani, Tadatoshi Takayama |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2013-03-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/350558 |
Similar Items
-
The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma
by: Jia-Xin Li, et al.
Published: (2012-09-01) -
Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis
by: Jiani Zhao, et al.
Published: (2020-01-01) -
Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas
by: Tai-Yang Zuo, et al.
Published: (2017-01-01) -
Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis
by: Chuang Jiang, et al.
Published: (2021-03-01) -
Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)